Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender

Table 1

Clinical characteristics of patients with AF and controls with NSR.

Clinical characteristics	AF (n = 84)	NSR (n = 84)	value
Age (years)	61.3 ± 10.3	60.7 ± 10.8	0.705
Men (n/%)	56 (67)	56 (67)	1.000
Body mass index (kg/m^2)	24.8 ± 3.3	24.2 ± 3.2	0.400
Hypertension (n/%)	40 (48)	44 (52)	0.537
Diabetes mellitus (n/%)	10 (12)	7 (8)	0.443
Smoking (n/%)	19 (23)	28 (33)	0.314
Drinking (n/%)	16 (19)	11 (13)	0.294
ACEI/ARB (n/%)	26 (31)	22 (26)	0.738
TZDs (n/%)	2 (2.4)	3 (3.6)	0.652
Paroxysmal AF (n/%)	57 (68)	—	—
Persistent AF (n/%)	27 (32)	—	—
NT-proBNP (pg/ml)	321.2 (113.1–716.7)	55.5 (25.6–110.2)	<0.001
cTnI (ng/ml)	0.006 (0.006–0.125)	0.006 (0.006–0.006)	0.001
Hs-CRP (mg/L)	0.68 (0.50–1.24)	0.81 (0.50–1.89)	0.643
Fasting glucose (mmol/L)	4.96 (4.57–5.78)	4.88 (4.44–5.87)	0.951
Uric acid (μmol/L)	384.3 ± 92.1	400.5 ± 123.7	0.339
Total cholesterol (mmol/L)	4.19 ± 0.81	4.52 ± 0.89	0.015
Triglycerides (mmol/L)	1.53 (1.10–2.28)	1.88 (1.16–2.69)	0.090
HDL-cholesterol (mmol/L)	1.17 ± 0.45	1.13 ± 0.33	0.499
LDL-cholesterol (mmol/L)	2.36 ± 0.68	2.59 ± 0.82	0.048
eGFR (mL/min)	93.7 ± 19.4	95.8 ± 19.5	0.496
Left atrium diameter (mm)	40.2 ± 5.6	34.4 ± 4.1	<0.001
LVEDD (mm)	44.9 ± 5.5	44.0 ± 3.6	0.199
LVEF (%)	57.7 ± 3.1	59.9 ± 1.9	<0.001

Continuous variables are presented as mean ± SD or median and IQR. Categorized variables are presented as number (percentage). values < 0.05 are indicated in bold. AF, atrial fibrillation; NSR, normal sinus rhythm; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin type II receptor blockers; TZD, thiazolidinedione; NT-proBNP, N-terminal probrain natriuretic peptide; cTnI, cardiac troponin I; hs-CRP, high-sensitivity C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; eGFR, estimated glomerular filtration rate; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricle ejection fraction.